Jl. Wang et al., Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension, HYPERTENSIO, 34(1), 1999, pp. 96-101
Citations number
38
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
It has been proposed that the macula densa participates in the regulation o
f increased renin expression in renovascular hypertension (RVH) and that pr
ostaglandins may be among the mediators of macula densa function. We have p
reviously shown that in renal cortex, cyclooxygenase-2 (COX-2) expression i
s localized to the macula densa and surrounding cortical thick ascending li
mb and increases in high-renin states, such as salt restriction and angiote
nsin-converting enzyme inhibition. In the present studies, we examined the
effect of the selective COX-2 inhibitor SC58236 on plasma renin activity (P
RA) and renal renin expression in: RVH in rats. The aorta was coarcted betw
een-right and left renal arteries, and animals received either SC58236 or v
ehicle for 1 week. At day 8, vehicle-treated coarcted rats were hypertensiv
e (mean carotid arterial blood pressure: 138+/-3 versus 87+/-2 mm Hg in sha
m-operated controls, n=9 to II; P<0.001) and exhibited a disparity of kidne
y size (ratio left/right kidney: 0.78+/-0.04 versus 1.02+/-0.02; n=9 to 10;
P<0.001). PRA increased significantly (84.6+/-6.5 versus 9.0+/-1.4 ng angi
otensin I [Ang I] per milliliter per hour; n=8 to 9; P<0.01). In the coarct
ed rats, neither renin mRNA expression nor renin activity of the right kidn
ey was altered (renin/GAPDH mRNA: 1.12+/-0.05-fold levels in control rats;
n=6; P=NS; renin activity: 23.4+/-1.8 versus 27.1+/-3.4 ng Ang I per hour p
er milligram protein; n=8 to 9; P=NS). However, the renin mRNA of the left
kidney increased to 3.0+/-0.6-fold of control (n=6), and the renin activity
increased to 189.0+/-28.6 ng Ang I per hour per milligram protein (n=8; P<
0.01). Expression of COX-2 mRNA and immunoreactive protein increased in the
affected left kidney but was not different from control in the unaffected
right kidney. SC58236 treatment to coarcted rats did not affect kidney size
(ratio left/right kidney: 0.79+/-0.06; n=9). However, PRA was significantl
y decreased compared with the vehicle-treated coarcted rats (19.8+/-2.8 ng
Ang I per milliliter per hour; n=9; P<0.01). The left kidney renin mRNA and
renin content were also decreased (1.7+/-0.3-fold control; n=6; P<0.05; an
d 45.7+/-7.6 ng Ang I per hour per milligram protein; n=9; P<0.01, respecti
vely), while renin mRNA and renin content of the right kidney were not alte
red: SC58236 lowered mean arterial blood pressure (122+/-5 mm Hg; n=14; P<0
.05 compared with vehicle). A significant correlation was observed between
PRA. and mean blood pressure (r=0.75; P<0.01). In summary, these studies in
dicate that the selective COX-2 inhibitor SC58236 decreases renin productio
n and release in RVH and suggest an important role for COX-2 regulation of
the renin-angiotensin system.